Research and development of innovative medicines to promote mental health are a priority for America’s biopharmaceutical research companies. With more than 130 medicines in development for mental illness, biopharmaceutical scientists are making discoveries in the lab that put treatments in the hands of patients.
Now, more than ever, we understand that the appropriate treatment of mental health conditions, once they are first recognized, can change the trajectory of an individual’s life for the better. Here at PhRMA, we are committed to the innovation that brings the next breakthrough possible and puts over 40 million patients who suffer from mental illness on the right track.
To dig deeper on mental health, PhRMA is continuing our national dialogue series with “New Cures, New Innovators for a New Era in Mental Health” today, April 18, in partnership with Axios. This event will convene leading voices to explore the current state of mental health, the science that has revolutionized treatment options and the roles that the biopharmaceutical industry, advocacy organizations and technology play to make possible these new medicines.
The program will be streamed live from 3:00 - 4:30 pm CT/4:00 - 5:30 ET, and those interested can join the conversation on Twitter with @PhRMA and #GoBoldy.
To learn more about the positive impact of the work being done by America’s biopharmaceutical companies, visit www.innovation.org.
Bill Chin M D
Dr. Bill Chin is the former chief medical officer of PhRMA and led the Scientific & Regulatory Advocacy department as executive vice president through the fall of 2017.
Bill Chin M D
Advancing mental health in May and beyond
World Mental Health Day: Supporting access to medicines that help loved ones
The role of antidepressants in addressing America’s mental health crisis
Mental Health Awareness Month: Supporting loved ones and improving mental health in America
Women’s Health Month: A conversation with Sage
Addressing Mental Health: A conversation with Barry Greene, CEO of Sage Therapeutics
Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation
New Report More than 160 medicines in development for mental illness
New paper: Addressing the growing crisis of mental health and substance use disorders
Mental Illness Awareness Week – A time for reflection
Spotlighting a growing mental health challenge
A conversation with Barry Greene, CEO of Sage Therapeutics
Guest post: Joining forces to combat the COVID-19 mental health crisis
Guest Blog: COVID-19 vaccines are the key to keeping kids healthy
Coming together to fight COVID-19: A conversation with Barry Greene, CEO of Sage Therapeutics
Reflecting on Mental Health Awareness Month
Action needed to preserve the six protected classes
Coming together to fight COVID-19: A conversation with Kabir K. Nath, President & CEO of Otsuka North America Pharmaceutical Bu
Guest Post: Recognizing America’s Veterans
Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
Guest post: A post-pandemic crisis: The mental toll on America
Guest post: Looking out for the invisibly vulnerable in the time of COVID-19
Nearly 140 medicines in development to treat mental illness
ICYMI: Fighting for a cure to ALS
"If Washington isn’t careful, we might leave innovation behind"
Giving patients a voice: PhRMA launches Voters for Cures to support the next generation of treatments and cures
New report shows nearly 300 cell and gene therapies in development
New report shows more than 300 skin disease medicines in development
Event next week: Supporting the next generation of lifesaving medicines
Aspen Spotlight Health: Discussing the forefront of innovation
Event tomorrow: Improving patient access to lifesaving medicines
ICYMI: Report highlights increasing prevalence for Alzheimer’s disease
New report and event examine the new era of vaccines
A new era in cancer
2017 Research & Hope Awards honor innovators in mental health
Working to harness the power of the body’s own immune system
Going boldly together: New advancements and new anniversaries
Examining the brain in The New Era of Medicine
Modernizing FDA regulations to advance a value-driven health care system
Opening the conversation around mental health treatment with advocates & industry leaders
Fighting multiple sclerosis: New Together ad illuminates the journey of patient & scientist
ICYMI: Avalere and FasterCures develop new value framework from patient perspective
A New World of Medicine: New GOBOLDLY ads showcase groundbreaking scientific advancements
ICYMI: The New Era of Medicine initiative spotlights genomics in NYC
A new era in genomics
This is not a special effect: New video shows the destruction of a rogue cell
Exploring the new era of medicine
PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check
This is not a video game: New TV ad showcases the destruction of a cancer cell by immune system
VIDEO: PhRMA CEO discusses #GOBOLDLY campaign and White House meeting with CNNMoney’s Maggie Lake
The Value Collaborative: Advancing private market solutions to achieve better health, lower costs
VIDEO: PhRMA CEO joins CNBC’s Squawk on the Street to discuss industry campaign #GOBOLDLY
Mental health in the New Era of Medicine
GoBoldly
Mental Health
Mental health in the New Era of Medicine
Mental health in the New Era of Medicine